Varex Imaging Corporation reported a net revenue of $466.5 million for the fiscal year ending October 3, 2025, marking a 7.5% increase from the previous year's revenue of $434.5 million. The company's profitability, however, was impacted by a significant goodwill impairment charge of $93.9 million, resulting in a net loss of $69.9 million compared to a net loss of $48.3 million in fiscal year 2024. The increase in revenue was driven by a $10.9 million rise in medical segment sales, primarily from CT, oncology, and mammography products, and a $22.7 million increase in industrial segment sales, particularly in security inspection products and X-ray tubes.

The company experienced notable changes in its operational landscape, including a shift in revenue distribution across geographic regions. The Americas saw a revenue increase of $10 million, while EMEA and APAC regions reported increases of $4.5 million and $19.1 million, respectively. Varex's customer base remains concentrated, with its top five customers accounting for approximately 40% of total revenue. Canon Medical Systems Corporation was the largest customer, contributing 18% of total revenue.

Strategically, Varex has focused on expanding its manufacturing capabilities in response to the ongoing U.S.-China trade tensions and tariffs, which have affected its cost structure and competitive positioning. The company has implemented a local-for-local strategy to mitigate tariff impacts and enhance its supply chain resilience. Additionally, Varex is actively pursuing new applications for its technology in the non-destructive testing sector, which it identifies as a significant growth opportunity.

Operationally, Varex employed approximately 2,400 full-time equivalent employees as of October 3, 2025, with a continued emphasis on research and development, which accounted for 10.8% of total revenue. The company reported a backlog of approximately $262 million, indicating a solid pipeline of future revenue. However, the company faces challenges related to supply chain disruptions and fluctuating material costs, which could impact its ability to meet customer demand and maintain profitability.

Looking ahead, Varex anticipates continued volatility in its operating environment due to geopolitical tensions, economic instability, and regulatory changes. The company remains committed to enhancing its product offerings and operational efficiencies while navigating the complexities of the current market landscape.

About Varex Imaging Corp

Varex Imaging Corporation designs and manufactures X-ray imaging components, including X-ray tubes, detectors, and software, serving medical, security, and industrial markets worldwide. Its core business involves supplying OEMs with customized, high-performance imaging solutions for diagnostic, security, and non-destructive testing applications. The company leverages technological innovation, scale, and long-term customer relationships to maintain competitive advantage in a highly regulated, global industry.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-K Filings

A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.

Key points about the 10-K:

  • Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
  • Content: It includes:
    • Detailed financial statements audited by an independent accounting firm
    • Management's Discussion and Analysis (MD&A) of financial condition and results
    • Description of the company's business, properties, and legal proceedings
    • Risk factors and market risks
    • Executive compensation and corporate governance information
  • Importance: Considered the most comprehensive and important document a public company files with the SEC.
  • Length: Often exceeds 100 pages due to its extensive and detailed nature.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.